HK University introduces AI-powered tool for heart disease prediction

P-CARDIAC’s effectiveness will be evaluated in the HEARTWISE study.

Hong Kong University introduced P-CARDIAC, an AI-powered risk prediction tool for heart disease, P-CARDIAC.

P-CARDIAC incorporates 120 risk factors to provide personalised risk scores for patients. Its effectiveness will be evaluated in the HEARTWISE study, recruiting over 3,000 patients in the fourth quarter of 2024.

Anyone aged 18 to 80 with a history of cardiovascular events, under follow-up care in a general medicine or cardiology outpatient clinic with no cognitive decline or physical disabilities can join the study.

“The ultimate goal is to incorporate P-CARDIAC into routine clinical practice, leading to improved cardiovascular health outcomes for millions,” Professor Yiu Kai-hang, Clinical Professor in Cardiology Division at University of Hong Kong, said. 

In addition to the HEARTWISE study, a pilot study was also launched in a primary care setting in collaboration with the Hong Kong Society of Rehabilitation (HKSR).

Preliminary results indicated that over 90% of patients experienced a change in their P-CARDIAC score by the second visit, two months after the first. Of the 20 recruited, 15 had follow-up visits, and 80% reported an improved understanding of their CVD risk.